Treatment outcomes for multidrug- and rifampicin-resistant tuberculosis in Central and West Africa: a systematic review and meta-analysis

•Multidrug-resistant/rifampicin-resistant tuberculosis remains a major threat to global health, mainly in low-income settings.•We found a successful treatment outcome of 74.6% in Central and West Africa.•The World Health Organization reported an average global success rate of 59% in 2018.•Shorter an...

Full description

Saved in:

Bibliographic Details
Published in:	International journal of infectious diseases Vol. 124; pp. S107 - S116
Main Authors:	Toft, Asbjørn Langeland, Dahl, Victor Næstholt, Sifna, Armando, Ige, Olusoji Mayowa, Schwoebel, Valérie, Souleymane, Mahamadou Bassirou, Piubello, Alberto, Wejse, Christian
Format:	Journal Article
Language:	English
Published:	Canada Elsevier Ltd 01.11.2022 Elsevier
Subjects:	Africa Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use Directly Observed Therapy Drug-resistance Epidemiology Humans Mycobacterium tuberculosis Rifampin - pharmacology Rifampin - therapeutic use Treatment Outcome Tuberculosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - epidemiology Treatment outcome Tuberculosis Drug-resistance Epidemiology Africa
ISSN:	1201-9712, 1878-3511, 1878-3511
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!